References

  1. Grosshans EM. The red face: Erysipelas. Clin Dermatol. 1993;11(2):307-313. PubMed | Google Scholar

  2. Bernard P, Bedane C, Mounier M, Denis F, Bonnetblanc JM. Dermohypodermites bacteriennes de I'adulte: incidence et place de l'étiologie streptococcique. Ann DermatolVenereol. 1995;122(8):495-500. PubMed | Google Scholar

  3. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med. 1996;334(4):240-245. PubMed | Google Scholar

  4. Bonnetblanc JM, Bedane C. Erysipelas: recognition and management. Am J Clin Dermatol. 2003;4(3):157-163. PubMed | Google Scholar

  5. Linke M, Booken N. Risk factors associated with a reduced response in the treatment of erysipelas. J Dtsch Dermatol Ges. 2015 Mar;13(3):217-225. PubMed | Google Scholar

  6. Crickx B. Erysipčle: évolution médicale sous traitement: Complications. Ann Dermatol Venereol. 2001 Mar;128(3 Pt 2):358-362. PubMed | Google Scholar

  7. Jorup-Ro¨nstro¨m C. Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis. 1986;18(6):519-524. PubMed | Google Scholar

  8. Chartier C, Grosshans E. Erysipelas. Int J Dermatol. 1990;29(7):459-467. PubMed | Google Scholar

  9. Krasagakis K, Samonis G, Valachis A, Maniatakis P, Evangelou G, Tosca A. Local complications of erysipelas: a study of associated risk factors. Clin Exp Dermatol. 2011;36(4):351-354. PubMed | Google Scholar

  10. Picard D, Klein A, Grigioni S, Joly P. Risk factors for abscess formation in patients with superficial cellulitis (erysipelas) of the leg. Br J Dermatol. 2013 Apr;168(4):859-863. PubMed | Google Scholar

  11. Schrock JW, Laskey S, Cydulka RK. Predicting observation unit treatment failures in patients with skin and soft tissue infections. Int J Emerg Med. 2008;1(2):85-90. PubMed | Google Scholar

  12. Bartholomeeusen S, Vandenbroucke J, Truyers C, Buntix F. Epidemiology and comorbidity of erysipelas in primary care. Dermatology. 2007;215(2):118-122. PubMed | Google Scholar

  13. Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ. 1999;318(7198):1591-1594. PubMed | Google Scholar

  14. Musette P, Benichou J, Noblesse I, Hellot MF, Carvalho P, Younget P et al. Determinants of severity for superficial cellulitis (erysipelas) of the leg: a retrospective study. Eur J Intern Med. 2004;15(7):446-450. PubMed | Google Scholar

  15. Concheiro J, Loureiro M, González-Vilas D, García-Gavín J, Sánchez-Aguilar D, Toribio J. Erysipelas and cellulitis: a retrospective study of 122 cases. Actas Dermosifiliogr. 2009 Dec;100(10):888-894. PubMed | Google Scholar

  16. Lazzarini L, Conti E, Tositti G, deLalla F. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect. 2005;51(5): 383-389. PubMed | Google Scholar

  17. Dupuy A. Epidémiologie descriptive et connaissance des facteurs de risque de l’érysipčle. Ann Dermatol Venereol. 2001;128(3 Pt 2):312-316. PubMed | Google Scholar

  18. Carratalŕ J, Rosón B, Fernández-Sabé N, Shaw E, del Río O, Rivera A et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis. 2003;22(3):151-157. PubMed | Google Scholar